UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017054
Receipt number R000019778
Scientific Title Evaluation of analgesic effects in healthy adults. -Using Cold Pressor Test-
Date of disclosure of the study information 2015/05/11
Last modified on 2015/12/15 14:58:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of analgesic effects in healthy adults.
-Using Cold Pressor Test-

Acronym

Evaluation of analgesic effects after administration of analgesics using Cold Pressor Test.

Scientific Title

Evaluation of analgesic effects in healthy adults.
-Using Cold Pressor Test-

Scientific Title:Acronym

Evaluation of analgesic effects after administration of analgesics using Cold Pressor Test.

Region

Japan


Condition

Condition

Cancer Pain

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Analgesic effects after the administration of Oxycodone HCL (10mg) or placebo will be compared using 2x2 crossover methods.

Basic objectives2

Pharmacodynamics

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Analgesic effects of Oxycodone HCL administration

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Single oral administration of Oxycodone HCL (10mg)

Interventions/Control_2

Single oral administration of placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >=

Gender

Male

Key inclusion criteria

1, Healthy Japanese male subjects who provide signed written informed consent.
2, Subjects between 20 and 40 (inclusive) year of age at the time of consent.
3, Subjects with BMI <=18.5 and >25.0 at the time of screening.
4, Subjects judged as adequate for this study by study physician.

Key exclusion criteria

1, Subjects with present illness which requires treatment.
2, Subjects with past medical history which was considered not adequate for this study.
3, Subjects with past history of drug allergy.
4, Subjects with history of caffeine, alcohol and/or drug abuse.
5, Subjects who was judged not appropriate for this study by study physician.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masanari Shiramoto

Organization

Medical Co. LTA Hakata Clinic

Division name

Clinical Pharmacology Department

Zip code


Address

Random Square (5th-7th floors), 6-18 Tenyamachi, Hakata-ku, Fukuoka 812-0025

TEL

0922837701

Email

masanari-shiramoto@lta-med.com


Public contact

Name of contact person

1st name
Middle name
Last name Hinako Uchimaru

Organization

Medical Co. LTA Hakata Clinic

Division name

Planning & Coordination Dept.

Zip code


Address

Random Square (5th-7th floors), 6-18 Tenyamachi, Hakata-ku, Fukuoka 812-0025

TEL

0922837701

Homepage URL


Email

hinako-uchimaru@lta-med.com


Sponsor or person

Institute

Medical Co. LTA Hakata Clinic

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人相生会 博多クリニック(福岡県)


Other administrative information

Date of disclosure of the study information

2015 Year 05 Month 11 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 03 Month 20 Day

Date of IRB


Anticipated trial start date

2015 Year 05 Month 11 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Poster presentation at the 36th Annual Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics (Dec.9-11,2015) "Phamacodynamic evaluation of analgesics in healthy subjects - evaluation of Cold Pressor Test-"


Management information

Registered date

2015 Year 04 Month 06 Day

Last modified on

2015 Year 12 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019778


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name